Financial analysts covering the Claranova share (CLA.PA)
Weak Q1 leads us to cut our FY 2026 estimates
FY 2024/25 review: First take
Still an appealing story, execution key
Mixed full-year results; 2028 targets reiterated, but visibility remains limited
Q4 revenue still down sharply- Targets reset for 2028
Decline in activity in Q1 due to continued focus on profitability
